A Plain Language Summary of the Final Analysis of the Griffin Study of Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone for People With Newly Diagnosed Multiple Myeloma

Authors

Peter M Voorhees
Douglas W Sborov
Jacob Laubach
Jonathan L Kaufman
Brandi Reeves
Cesar Rodriguez
Rebecca Silbermann
Luciano J Costa
Larry D Anderson
Nitya Nathwani
Nina Shah
Naresh Bumma
Yvonne A Efebera
Sarah A Holstein
Caitlin Costello
Andrzej Jakubowiak
Tanya M Wildes
Robert Z Orlowski
Kenneth H Shain
Andrew J Cowan
Shira Dinner
Katharine S Gries
Huiling Pei
Annelore Cortoos
Sharmila Patel
Thomas S Lin
Saad Z Usmani
Paul G Richardson

Publication Date

1-1-2025

Journal

Future Oncology

DOI

10.1080/14796694.2024.2408909

PMID

39452950

PMCID

PMC11789466

PubMedCentral® Posted Date

10-25-2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Voorhees, Peter M; Sborov, Douglas W; Laubach, Jacob; et al., "A Plain Language Summary of the Final Analysis of the Griffin Study of Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone for People With Newly Diagnosed Multiple Myeloma" (2025). Faculty, Staff and Student Publications. 3713.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/3713